User profiles for M. Abulafi

Muti Abulafi

Consultant Colorectal Surgeon, Croydon University Hospital
Verified email at nhs.net
Cited by 4519

[HTML][HTML] Role of the faecal immunochemical test in patients with risk-stratified suspected colorectal cancer symptoms: A systematic review and meta-analysis to inform …

…, M Westwood, J Kleijnen, M Abulafi - The Lancet Regional …, 2022 - thelancet.com
Background The UK National Institute for Health and Care Excellence (NICE), recommended
in 2017 the use of the faecal immunochemical test (FIT) to guide investigations in patients …

[HTML][HTML] Prognostic importance of MRI-detected extramural venous invasion in rectal cancer: a literature review and systematic meta-analysis

JJ Tan, RV Carten, A Babiker, M Abulafi… - International Journal of …, 2021 - Elsevier
Purpose Extramural venous invasion (EMVI) is recognized as a poor prognostic factor in
rectal cancer. There are well-documented limitations associated with pathology detection of …

Faecal immunochemical test is superior to symptoms in predicting pathology in patients with suspected colorectal cancer symptoms referred on a 2WW pathway: a …

N D'Souza, TG Delisle, M Chen, S Benton, M Abulafi - Gut, 2021 - gut.bmj.com
Objective To assess whether a faecal immunochemical test (FIT) could be used to select
patients with suspected colorectal cancer (CRC) symptoms for urgent investigation. Design …

MRI-diagnosed tumor deposits and EMVI status have superior prognostic accuracy to current clinical TNM staging in rectal cancer

…, A Shaw, Z Rokan, B Moran, M Abulafi… - Annals of …, 2022 - journals.lww.com
Objective: We aimed to assess whether mrTDs and mrLNMs have different prognostic
implications and compare these to other known prognostic markers. Methods: This was a …

The rectosigmoid problem

…, MPMN tot Babberich, A Lord, A Shaw, M Abulafi… - Surgical Oncology, 2018 - Elsevier
The lack of consensus over the transition point for the end of the sigmoid and beginning of
the rectum is a problem for the colorectal multidisciplinary team. In this review, we survey the …

Faecal immunochemical testing (FIT) in patients with signs or symptoms of suspected colorectal cancer (CRC): a joint guideline from the Association of Coloproctology …

KJ Monahan, MM Davies, M Abulafi, A Banerjea… - Gut, 2022 - gut.bmj.com
Faecal immunochemical testing (FIT) has a high sensitivity for the detection of colorectal
cancer (CRC). In a symptomatic population FIT may identify those patients who require …

Prioritisation by FIT to mitigate the impact of delays in the 2-week wait colorectal cancer referral pathway during the COVID-19 pandemic: a UK modelling study

…, DC Muller, G Lyratzopoulos, M Lawler, M Abulafi… - Gut, 2021 - gut.bmj.com
Objective To evaluate the impact of faecal immunochemical testing (FIT) prioritisation to
mitigate the impact of delays in the colorectal cancer (CRC) urgent diagnostic (2-week-wait (…

Whole‐genome methylation analysis of benign and malignant colorectal tumours

…, A Jones, M El‐Bahwary, M Abulafi… - The Journal of …, 2013 - Wiley Online Library
Abstract Changes in DNA methylation, whether hypo‐ or hypermethylation, have been
shown to be associated with the progression of colorectal cancer. Methylation changes …

Adverse features on rectal MRI identify a high-risk group that may benefit from more intensive preoperative staging and treatment

…, G Artho, R Lisbona, P Tekkis, M Abulafi… - Annals of surgical …, 2012 - Springer
Background Magnetic resonance imaging (MRI) is highly accurate in local staging of rectal
cancer. It can identify features known to be associated with increased risk of metastatic …

[HTML][HTML] Loss of expression of the double strand break repair protein ATM is associated with worse prognosis in colorectal cancer and loss of Ku70 expression is …

…, M Novelli, M Abulafi, SV Hodgson, W Fadhil, M Ilyas… - Oncotarget, 2012 - ncbi.nlm.nih.gov
Repair of double strand DNA breaks (DSBs) is pivotal in maintaining normal cell division
and disruption of this system has been shown to be a key factor in carcinogenesis. Loss of …